Literature DB >> 20610830

Age-related prolongation of phase I of VO2 on-kinetics in healthy humans.

Alessandro Mezzani1, Bruno Grassi, Andrea Giordano, Ugo Corrà, Silvia Colombo, Pantaleo Giannuzzi.   

Abstract

Data are lacking regarding age-related modifications of phase I (PhI) of pulmonary Vo(2) on-kinetics during moderate-intensity exercise. We studied three groups (aged 20-30, 40-50, and 60-70 years) of 10 normal subjects, who underwent one incremental and four below-gas exchange threshold constant-power cardiopulmonary exercise tests. Data from constant-power tests were time-aligned and averaged, and the PhI-phase II transition (PhI-IItr) determined when a sharp decrease from baseline of respiratory exchange ratio occurred. The Vo(2) phase II time constant (tau) was obtained by an exponential fitting starting 1) from PhI-IItr ("experimental" fitting strategy) and 2) after 20 s from exercise onset ("fixed-duration" fitting strategy). Assuming estimated arterial-venous O(2) concentration difference not to change with respect to resting value, cardiac output (CO) values at rest and PhI-IItr were obtained according to Fick's principle. Average pulmonary flow acceleration (AFA) during PhI was calculated as the ratio between CO increase during PhI and PhI duration. PhI duration was related to age (r = 0.74, P < 0.0001), increasing from 21 +/- 3 s to 27 +/- 3 s to 32 +/- 4 s in the 20-30, 40-50, and 60-70 age groups, respectively, and to AFA (r = -0.60, P < 0.001), but not to CO increase during PhI. With respect to the experimental fitting strategy, the fixed-duration strategy overestimated Vo(2) phase II tau the more the higher the subject's age, with a lower goodness of fit in the 60-70 group (SE 0.035 vs. 0.056, P < 0.01). In conclusion, PhI duration is related to age in healthy male humans and is linked to CO acceleration-rather than to increase-during PhI. A significant overestimation of phase II tau thus may occur in healthy elderly subjects and patients with a pathologically induced longer PhI duration when fitting data where the PhI-PhIItr was not experimentally determined but assumed to be a set value (i.e., 20 s).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610830     DOI: 10.1152/ajpregu.00739.2009

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  12 in total

1.  Cardiorespiratory kinetics: comparisons between athletes with different training habits.

Authors:  Jessica Koschate; Laura Gerlich; Veronika Wirtz; Lutz Thieschäfer; Uwe Drescher; Uwe Hoffmann
Journal:  Eur J Appl Physiol       Date:  2019-06-21       Impact factor: 3.078

2.  Impact of 60 days of 6° head down tilt bed rest on muscular oxygen uptake and heart rate kinetics: efficacy of a reactive sledge jump countermeasure.

Authors:  J Koschate; L Thieschäfer; U Drescher; U Hoffmann
Journal:  Eur J Appl Physiol       Date:  2018-06-26       Impact factor: 3.078

3.  Temporal dissociation between muscle and pulmonary oxygen uptake kinetics: influences of perfusion dynamics and arteriovenous oxygen concentration differences in muscles and lungs.

Authors:  U Drescher; J Koschate; L Thieschäfer; S Schneider; U Hoffmann
Journal:  Eur J Appl Physiol       Date:  2018-06-22       Impact factor: 3.078

4.  Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes.

Authors:  Felix Stader; Marco Siccardi; Manuel Battegay; Hannah Kinvig; Melissa A Penny; Catia Marzolini
Journal:  Clin Pharmacokinet       Date:  2019-04       Impact factor: 6.447

5.  Non-invasive estimation of muscle oxygen uptake kinetics with pseudorandom binary sequence and step exercise responses.

Authors:  Uwe Drescher; R Schmale; J Koschate; L Thieschäfer; T Schiffer; S Schneider; U Hoffmann
Journal:  Eur J Appl Physiol       Date:  2017-12-18       Impact factor: 3.078

6.  V̇o2 kinetics associated with moderate-intensity exercise in heart failure: impact of intrathecal fentanyl inhibition of group III/IV locomotor muscle afferents.

Authors:  Erik H Van Iterson; Bruce D Johnson; Michael J Joyner; Timothy B Curry; Thomas P Olson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-05-05       Impact factor: 4.733

7.  Effects of aging and exercise training on spinotrapezius muscle microvascular PO2 dynamics and vasomotor control.

Authors:  Danielle J McCullough; Robert T Davis; James M Dominguez; John N Stabley; Christian S Bruells; Bradley J Behnke
Journal:  J Appl Physiol (1985)       Date:  2011-01-06

8.  Age-related symptom and life quality changes in women with irritable bowel syndrome.

Authors:  Yu-Rong Tang; Wei-Wei Yang; Mei-Lan Liang; Xin-Yu Xu; Mei-Feng Wang; Lin Lin
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

9.  Changes in pulmonary oxygen uptake and muscle deoxygenation kinetics during cycling exercise in older women performing walking training for 12 weeks.

Authors:  Akiko Hamasaki; Saburo Arima; Kohji Hirakoba
Journal:  Eur J Appl Physiol       Date:  2018-07-25       Impact factor: 3.078

10.  V.O2 Kinetics and clinical factors among patients with peripheral artery disease.

Authors:  Raphael Mendes Ritti-Dias; Ji Li; Kimberly M Hollabaugh; Julie A Stoner; Polly S Montgomery; Andrew W Gardner
Journal:  J Cardiopulm Rehabil Prev       Date:  2013 Nov-Dec       Impact factor: 2.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.